<p class="MsoNormal">Last week, the UK government also announced that it had secured five million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273, hours after the biotech firm said it was 94.5% effective in preventing the virus based on interim data from its late-stage clinical trial.</p>
